EUVIMEDEUVIMED entdecken
Crossref

Noradrenergic modulation of Dex-ketoprofen analgesia in preclinical orofacial pain

Hugo F Miranda, Viviana Noriega, Francisca Moreno, Fernando Sierralta, Ramón Sotomayor-Zárate, Juan Carlos Prieto

International Journal of Frontiers in Biology and Pharmacy Research · 2022

DOI: 10.53294/ijfbpr.2022.3.1.0053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Frontiers in Biology and Pharmacy Research, 2022. Verfasst von Hugo F Miranda und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dexketoprofen (DEX) is the dextrorotatory enantiomer of S (+) configuration with a high antinociceptive activity of ketoprofen. The aim of this study was to evaluate the pharmacological interaction of DEX with the noradrenergic antagonist's prazosin, yohimbine, propranolol and atenolol in the formalin orofacial pain in mice. Analgesia to nociceptive and inflammatory pain was evaluated by dose response curves to DEX before and after the i.p. administration of 1.0 mg/kg of prazosin, or yohimbine, or propranolol or atenolol. Results are presented as means ± SEM and differences were calculated by one-way ANOVA, followed by Tukey’s post-test. DEX produced a dose-related antinociceptive effect with varying potencies in both trial phases, with prazosin and yohimbine increasing the efficacy of DEX and propranolol and atenolol having no effect. These findings suggests that the increased efficacy of DEX cannot be explained by only inhibition of COXs, since it may be a consequence of multiple pharmacodynamic interactions induced by the activation of a-adrenoceptors in the opioidergic, cannabinoid, nitrergic or serotonergic mechanisms involved in pain. These results indicate that the combination of DEX with prazosin or yohimbine could be a new and effective alternative for the management of pain.

Zitieren

APA

Miranda, H. F., Noriega, V., Moreno, F., Sierralta, F., Sotomayor-Zárate, R., & Prieto, J. C. (2022). Noradrenergic modulation of Dex-ketoprofen analgesia in preclinical orofacial pain. International Journal of Frontiers in Biology and Pharmacy Research. https://doi.org/10.53294/ijfbpr.2022.3.1.0053

Vancouver

Miranda HF, Noriega V, Moreno F, Sierralta F, Sotomayor-Zárate R, Prieto JC. Noradrenergic modulation of Dex-ketoprofen analgesia in preclinical orofacial pain. International Journal of Frontiers in Biology and Pharmacy Research. 2022. doi:10.53294/ijfbpr.2022.3.1.0053

BibTeX
@article{Miranda2022,
  author = {Miranda, Hugo F and Noriega, Viviana and Moreno, Francisca and Sierralta, Fernando and Sotomayor-Zárate, Ramón and Prieto, Juan Carlos},
  title = {Noradrenergic modulation of Dex-ketoprofen analgesia in preclinical orofacial pain},
  journal = {International Journal of Frontiers in Biology and Pharmacy Research},
  year = {2022},
  doi = {10.53294/ijfbpr.2022.3.1.0053}
}
Kostenlos starten →